Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


29.08.2022

1 AJR Am J Roentgenol
1 Am J Cardiol
1 Am J Med
1 Angiology
1 Ann Intern Med
2 Arterioscler Thromb Vasc Biol
1 Atherosclerosis
1 Cardiovasc Res
1 Circ Cardiovasc Imaging
12 Circ J
1 Circ Res
1 Circulation
1 Hypertension
4 Int J Cardiol
4 J Am Coll Cardiol
4 J Cardiovasc Pharmacol
1 J Clin Endocrinol Metab
3 J Mol Cell Cardiol
3 JAMA
2 N Engl J Med
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LIPKIN I, Telluri A, Kim Y, Sidahmed A, et al
    Coronary CTA With AI-QCT Interpretation: Comparison With Myocardial Perfusion Imaging for Detection of Obstructive Stenosis UsingInvasive Angiography as Reference Standard.
    AJR Am J Roentgenol. 2022 Apr 20. doi: 10.2214/AJR.21.27289.
    PubMed         Abstract available


    Am J Cardiol

  2. WEXLER NZ, Vogrin S, Brennan AL, Noaman S, et al
    Adverse Impact of Peri-Procedural Stroke in Patients Who Underwent Percutaneous Coronary Intervention.
    Am J Cardiol. 2022 Aug 20. pii: S0002-9149(22)00737.
    PubMed         Abstract available


    Am J Med

  3. ECHOUFFO-TCHEUGUI JB, Zhang S, McEvoy JW, Ndumele CE, et al
    Elevated NT-proBNP as a cardiovascular disease risk equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study.
    Am J Med. 2022 Aug 23. pii: S0002-9343(22)00572.
    PubMed         Abstract available


    Angiology

  4. JIA F, Fei SF, Tong DB, Zhang S, et al
    Do Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries Have Similar Prognosis Compared to Ones with MI-CAD?
    Angiology. 2022 Aug 22:33197221121191. doi: 10.1177/00033197221121191.
    PubMed         Abstract available


    Ann Intern Med

  5. BOTTON J, Jabagi MJ, Bertrand M, Baricault B, et al
    Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.
    Ann Intern Med. 2022 Aug 23. doi: 10.7326/M22-0988.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  6. BI X, Stankov S, Lee PC, Wang Z, et al
    ILRUN Promotes Atherosclerosis Through Lipid-Dependent and Lipid-Independent Factors.
    Arterioscler Thromb Vasc Biol. 2022;42:1139-1151.
    PubMed         Abstract available

  7. ZIETZER A, Dusing P, Reese L, Nickenig G, et al
    Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic Potential.
    Arterioscler Thromb Vasc Biol. 2022 Aug 25:101161ATVBAHA122318048.
    PubMed         Abstract available


    Atherosclerosis

  8. NONG JC, You W, Xu T, Meng PN, et al
    Dynamic natural morphologies and component changes in nonculprit subclinical atherosclerosis in patients with acute coronary syndrome at 1-year follow-up and clinical significance at 3-year follow-up.
    Atherosclerosis. 2022;356:1-8.
    PubMed         Abstract available


    Cardiovasc Res

  9. ANG D, Berry C
    FAVOR III China: quantitative flow ratio-guided coronary intervention in practice.
    Cardiovasc Res. 2022;118:e78-e80.
    PubMed        


    Circ Cardiovasc Imaging

  10. VAIDYANATHAN B, Verma R, Kappanayil M, Kumar RK, et al
    Prenatal Diagnosis of a Large Left Coronary Artery to Right Ventricle Fistula With 3-Dimensional/4-Dimensional Spatiotemporal Image Correlation Rendering Followed by Successful Neonatal Transcatheter Closure.
    Circ Cardiovasc Imaging. 2022 Aug 26:101161CIRCIMAGING122014247.
    PubMed        


    Circ J

  11. CREA F, Montone RA, Rinaldi R
    Pathophysiology of Coronary Microvascular Dysfunction.
    Circ J. 2022;86:1319-1328.
    PubMed         Abstract available

  12. MURASATO Y
    How Should We Select 1- or 2-Stenting According to Coronary Bifurcation Lesion Complexity?
    Circ J. 2022;86:1376-1378.
    PubMed        

  13. NATSUAKI M, Morimoto T, Iimuro S, Fujita R, et al
    Thrombotic Risk Stratification and Intensive Statin Therapy for Secondary Prevention of Coronary Artery Disease- Insights From the REAL-CAD Study.
    Circ J. 2022;86:1416-1427.
    PubMed         Abstract available

  14. JANG AY, Kim M, Oh PC, Suh SY, et al
    Long-Term Clinical Outcomes and Its Predictors Between the 1- and 2-Stent Strategy in Coronary Bifurcation Lesions- A Baseline Clinical and Lesion Characteristic-Matched Analysis.
    Circ J. 2022;86:1365-1375.
    PubMed         Abstract available

  15. ABE S, Haruyama Y, Kobashi G, Toyoda S, et al
    Effect of Novel Stratified Lipid Risk by "LDL-Window" and Flow-Mediated Dilation on the Prognosis of Coronary Artery Disease Using the FMD-J Study A Data.
    Circ J. 2022;86:1444-1454.
    PubMed         Abstract available

  16. ISHIHARA T, Mizote I, Nakamura D, Okamoto N, et al
    Comparison of 1-Month and 12-Month Vessel Responses Between the Polymer-Free Biolimus A9-Coated Stent and the Durable Polymer Everolimus-Eluting Stent.
    Circ J. 2022;86:1397-1408.
    PubMed         Abstract available

  17. NUMASAWA Y
    Impact of Platelet Reactivity on Ischemic and Bleeding Events After Percutaneous Coronary Intervention- A Long-Term Perspective.
    Circ J. 2022;86:1350-1351.
    PubMed        

  18. SHIOMI H
    Paradigm Shift in Ischemia Evaluation and Accumulating Evidence of Safety of Deferred Coronary Revascularization on the Basis of Invasive Fractional Flow Reserve Measurement.
    Circ J. 2022;86:1337-1338.
    PubMed        

  19. TAKEISHI R, Yoshihisa A, Hotsuki Y, Anzai F, et al
    Temporal Trends in the Practice Pattern for Sleep-Disordered Breathing in Patients With Cardiovascular Diseases in Japan- Insights From the Japanese Registry of All Cardiac and Vascular Diseases - Diagnosis Procedure Combination.
    Circ J. 2022;86:1428-1436.
    PubMed         Abstract available

  20. SUGAI S, Matsumoto N, Makita A, Kuronuma K, et al
    Clinical Utility of a Slow (201)Tl Washout Rate in the Detection of Multi-Vessel Coronary Artery Disease Using a Simultaneous Acquisition Rest (99 m)Tc/Stress (201)Tl Protocol and a Semiconducting Gamma Camera.
    Circ J. 2022;86:1409-1415.
    PubMed         Abstract available

  21. NAKAMURA M, Yamano T, Asae Y, Takahata M, et al
    Coronary Vasospasm Complicated by Intercoronary Communication.
    Circ J. 2022;86:1477.
    PubMed        

  22. UEKI Y, Kuramitsu S, Saigusa T, Senda K, et al
    Long-Term Outcomes in Elderly Patients After Deferral of Coronary Revascularization Guided by Fractional Flow Reserve.
    Circ J. 2022;86:1329-1336.
    PubMed         Abstract available


    Circ Res

  23. CAI W, Xu D, Zeng C, Liao F, et al
    Modulating Lysine Crotonylation in Cardiomyocytes Improves Myocardial Outcomes.
    Circ Res. 2022;131:456-472.
    PubMed         Abstract available


    Circulation

  24. GREENLAND P, Maron DJ, Budoff MJ
    Insurance Payers Should Cover Selective Coronary Artery Calcium Testing in Intermediate Risk Primary Prevention Patients.
    Circulation. 2022;146:585-586.
    PubMed        


    Hypertension

  25. JIAN Z, Yuan C, Ma Y
    Blood Pressure Mediated the Effects of Urinary Uromodulin Levels on Myocardial Infarction: a Mendelian Randomization Study.
    Hypertension. 2022 Aug 25:101161HYPERTENSIONAHA12219670.
    PubMed         Abstract available


    Int J Cardiol

  26. DE FILIPPO O, Russo C, Manai R, Borzillo I, et al
    Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.
    Int J Cardiol. 2022 Aug 17. pii: S0167-5273(22)01201.
    PubMed         Abstract available

  27. STAHLI BE, Witassek FF, Roffi M, Eberli FR, et al
    Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry.
    Int J Cardiol. 2022 Aug 19. pii: S0167-5273(22)01200.
    PubMed        

  28. GHAJAR A, Ordonez CP, Philips B, Pinzon PQ, et al
    Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
    Int J Cardiol. 2022 Aug 21. pii: S0167-5273(22)01253.
    PubMed         Abstract available

  29. DEMIRKIRAN A, van der Geest RJ, Hopman LHGA, Robbers LFHJ, et al
    Association of left ventricular flow energetics with remodeling after myocardial infarction: New hemodynamic insights for left ventricular remodeling.
    Int J Cardiol. 2022 Aug 22. pii: S0167-5273(22)01250.
    PubMed         Abstract available


    J Am Coll Cardiol

  30. SANDHU RK, Dron JS, Liu Y, Moorthy MV, et al
    Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function.
    J Am Coll Cardiol. 2022;80:873-883.
    PubMed         Abstract available

  31. TSIMIKAS S, Marcovina SM
    Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:934-946.
    PubMed         Abstract available

  32. GOLDFARB M, De Hert M, Detraux J, Di Palo K, et al
    Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:918-933.
    PubMed         Abstract available

  33. FAGUNDES A JR, Morrow DA, Oyama K, Furtado RHM, et al
    Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial.
    J Am Coll Cardiol. 2022;80:887-897.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  34. ENNEZAT PV, Guerbaai RA, Marechaux S, Le Jemtel TH, et al
    Extent of LDL-cholesterol Reduction and All-cause and Cardiovascular Mortality Benefit: a Systematic Review and Meta-analysis.
    J Cardiovasc Pharmacol. 2022 Aug 23. pii: 00005344-990000000-00106.
    PubMed         Abstract available

  35. YANG S, Shen W, Zhang HZ, Wang CX, et al
    Efficacy and Safety of Finerenone for Prevention of Cardiovascular Events in Type 2 Diabetes Mellitus with Chronic Kidney Disease: A Meta-analysis of Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2022 Aug 23. pii: 00005344-990000000-00107.
    PubMed         Abstract available

  36. BURASHNIKOV A, Abbate A, Booz GW
    Cardiovascular complications of anti-cancer therapy: a developing storm in medicine.
    J Cardiovasc Pharmacol. 2022 Aug 15. pii: 00005344-990000000-00095.
    PubMed        

  37. AMIN G, Massoud G, Fares S, Booz GW, et al
    Colchicine and acute coronary syndromes: a new trick for an old drug?
    J Cardiovasc Pharmacol. 2022 Aug 18. pii: 00005344-990000000-00100.
    PubMed        


    J Clin Endocrinol Metab

  38. HOU T, Li M, Lin H, Zhao Z, et al
    The causal effect of systolic blood pressure lowering on vascular outcomes in diabetes: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Jun 15. pii: 6608757. doi: 10.1210.
    PubMed         Abstract available


    J Mol Cell Cardiol

  39. LI Y, Li C, Liu Q, Wang L, et al
    Loss of Acta2 in cardiac fibroblasts does not prevent the myofibroblast differentiation or affect the cardiac repair after myocardial infarction.
    J Mol Cell Cardiol. 2022;171:117-132.
    PubMed         Abstract available

  40. QI L, Wang Y, Hu H, Li P, et al
    m(6)A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-kappaB pathway and ROS production.
    J Mol Cell Cardiol. 2022;170:87-99.
    PubMed         Abstract available

  41. ZHU W, Sun J, Bishop SP, Sadek H, et al
    Turning back the clock: A concise viewpoint of cardiomyocyte cell cycle activation for myocardial regeneration and repair.
    J Mol Cell Cardiol. 2022;170:15-21.
    PubMed         Abstract available


    JAMA

  42. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:746-753.
    PubMed         Abstract available

  43. JIN J
    Statins for the Prevention of Cardiovascular Disease.
    JAMA. 2022;328:786.
    PubMed        

  44. CHOU R, Cantor A, Dana T, Wagner J, et al
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;328:754-771.
    PubMed         Abstract available


    N Engl J Med

  45. CASTELLANO JM, Pocock SJ, Bhatt DL, Quesada AJ, et al
    Polypill Strategy in Secondary Cardiovascular Prevention.
    N Engl J Med. 2022 Aug 26. doi: 10.1056/NEJMoa2208275.
    PubMed         Abstract available

  46. LINDHOLT JS, Sogaard R, Rasmussen LM, Mejldal A, et al
    Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMoa2208681.
    PubMed         Abstract available


    PLoS One

  47. MOONEY RE, Linden GJ, Winning L, Linden K, et al
    Association of TGFB1 rs1800469 and BCMO1 rs6564851 with coronary heart disease and IL1B rs16944 with all-cause mortality in men from the Northern Ireland PRIME study.
    PLoS One. 2022;17:e0273333.
    PubMed         Abstract available

  48. ABEYSURIYA V, Wijesinha NAI, Priyadharshan PP, Chandrasena LG, et al
    Composite carotid intima-media thickness as a risk predictor of coronary heart disease in a selected population in Sri Lanka.
    PLoS One. 2022;17:e0271986.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: